ImageneBio (IMA) Operating Leases (2021 - 2025)

ImageneBio has disclosed Operating Leases across 5 years of filings, most recently posting $713000.0 for Q4 2025.

• In Q4 2025, Operating Leases rose 198.33% year-over-year to $713000.0; the TTM figure through Dec 2025 stood at $713000.0 (up 198.33% YoY), while the FY2025 annual figure was $713000.0, up 198.33% from the prior year.
• Operating Leases came in at $713000.0 for Q4 2025 at ImageneBio, down from $1.3 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $8.0 million in Q3 2023 to a low of $239000.0 in Q4 2024.
• Average Operating Leases over 5 years is $4.2 million, with a median of $4.5 million recorded in 2022.
• Year-over-year, Operating Leases tumbled 96.67% in 2024 and soared 198.33% in 2025.
• Over 5 years, Operating Leases stood at $5.1 million in 2021, then fell by 26.25% to $3.8 million in 2022, then surged by 89.6% to $7.2 million in 2023, then plunged by 96.67% to $239000.0 in 2024, then jumped by 198.33% to $713000.0 in 2025.
• Per Business Quant data, the three most recent Operating Leases figures were $713000.0 in Q4 2025, $1.3 million in Q3 2025, and $1.8 million in Q2 2025.